Juvenile myelomonocytic leukemia
Active Research Protocols
- 01-C-0125 – Pilot Study of Non-Myeloablative, HLA-Matched Allogeneic Stem Cell Transplantation for Pediatric Hematopoietic Malignancies
- 04-C-0102 – Hematologic Malignancy Biology Study
- 06-C-0233 – A Phase I/II Study of the RAF Kinase and Receptor Tyrosine Kinase Inhibitor Sorafenib (BAY 43-9006, NSC# 724772 IND# 69896) in Children with Refractory Solid Tumors or Refractory Leukemias
- 08-C-0079 – Natural History Study and Longitudinal Assessment of Children, Adolescents, and Adults with Neurofibromatosis Type 1
NOTE: PDF documents require the freeAdobe Reader.
This page was last updated: January 24, 2014